Cite
MLA Citation
Peter G Pappas et al.. “123. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI).” Open forum infectious diseases, vol. 8, n.d., pp. S73–S74. http://access.bl.uk/ark:/81055/vdc_100150542630.0x000028